{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Topical+VEHICLE+cream", "query": { "intervention": "Topical VEHICLE cream" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 127, "total_pages": 13, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Topical+VEHICLE+cream&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-21T11:07:49.795Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00525499", "title": "A Phase 2 Study of ASC-J9 Cream in Acne Vulgaris", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acne Vulgaris" ], "interventions": [ { "name": "ASC-J9 cream", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AndroScience Corp", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 186, "start_date": "2007-08", "completion_date": "2008-07", "has_results": true, "last_update_posted_date": "2011-11-23", "last_synced_at": "2026-09-21T11:07:49.795Z", "location_count": 10, "location_summary": "Fremont, California • San Diego, California • Boise, Idaho + 7 more", "locations": [ { "city": "Fremont", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Boise", "state": "Idaho" }, { "city": "Paramus", "state": "New Jersey" }, { "city": "Albuquerque", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT00525499" }, { "nct_id": "NCT05219864", "title": "Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 1", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hand Eczema" ], "interventions": [ { "name": "Ruxolitinib cream", "type": "DRUG" }, { "name": "Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Incyte Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 0, "start_date": "2023-01-31", "completion_date": "2024-09-22", "has_results": false, "last_update_posted_date": "2022-11-17", "last_synced_at": "2026-09-21T11:07:49.795Z", "location_count": 26, "location_summary": "Phoenix, Arizona • Encino, California • Fountain Valley, California + 22 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Encino", "state": "California" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05219864" }, { "nct_id": "NCT04896385", "title": "A Study to Evaluate the Mechanism of Action of Ruxolitinib Cream in Subjects With Vitiligo (TRuE-V MOA)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Vitiligo" ], "interventions": [ { "name": "Ruxolitinib cream", "type": "DRUG" }, { "name": "Vehicle Cream", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Incyte Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2021-06-23", "completion_date": "2023-07-10", "has_results": true, "last_update_posted_date": "2025-08-05", "last_synced_at": "2026-09-21T11:07:49.795Z", "location_count": 6, "location_summary": "Fountain Valley, California • Irvine, California • Washington D.C., District of Columbia + 3 more", "locations": [ { "city": "Fountain Valley", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Brooklyn", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04896385" }, { "nct_id": "NCT01066585", "title": "A Safety and Efficacy Study Comparing 0.5% Ivermectin Cream to a Vehicle Control in Subjects With Head Lice Infestation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Head Lice" ], "interventions": [ { "name": "Ivermectin Cream", "type": "DRUG" }, { "name": "vehicle control", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Topaz Pharmaceuticals Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": null, "sex": "ALL", "summary": "6 Months and older" }, "enrollment_count": 410, "start_date": "2010-03", "completion_date": "2010-07", "has_results": true, "last_update_posted_date": "2012-04-06", "last_synced_at": "2026-09-21T11:07:49.795Z", "location_count": 8, "location_summary": "Yuma, Arizona • Dinuba, California • Plantation, Florida + 5 more", "locations": [ { "city": "Yuma", "state": "Arizona" }, { "city": "Dinuba", "state": "California" }, { "city": "Plantation", "state": "Florida" }, { "city": "West Palm", "state": "Florida" }, { "city": "Picayune", "state": "Mississippi" } ], "official_url": "https://clinicaltrials.gov/study/NCT01066585" }, { "nct_id": "NCT02661958", "title": "Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acne Vulgaris" ], "interventions": [ { "name": "S6G5T-3", "type": "DRUG" }, { "name": "S6G5T-1", "type": "DRUG" }, { "name": "S6G5T-5", "type": "DRUG" }, { "name": "S6G5T-6", "type": "DRUG" }, { "name": "S6G5T-7", "type": "DRUG" }, { "name": "S6G5T-8", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sol-Gel Technologies, Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "9 Years", "maximum_age": null, "sex": "ALL", "summary": "9 Years and older" }, "enrollment_count": 726, "start_date": "2016-05", "completion_date": "2017-10", "has_results": false, "last_update_posted_date": "2019-09-19", "last_synced_at": "2026-09-21T11:07:49.795Z", "location_count": 34, "location_summary": "Anaheim, California • Cerritos, California • Chula Vista, California + 27 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Cerritos", "state": "California" }, { "city": "Chula Vista", "state": "California" }, { "city": "Encino", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02661958" }, { "nct_id": "NCT05635838", "title": "Study to Evaluate of the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hidradenitis Suppurativa" ], "interventions": [ { "name": "Ruxolitinib cream", "type": "DRUG" }, { "name": "Vehicle cream", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Incyte Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 69, "start_date": "2022-12-07", "completion_date": "2024-03-14", "has_results": true, "last_update_posted_date": "2024-11-01", "last_synced_at": "2026-09-21T11:07:49.795Z", "location_count": 15, "location_summary": "Phoenix, Arizona • Fountain Valley, California • Boca Raton, Florida + 12 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Boca Raton", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Marietta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05635838" }, { "nct_id": "NCT03683719", "title": "Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand Eczema", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Hand Eczema" ], "interventions": [ { "name": "Delgocitinib cream", "type": "DRUG" }, { "name": "Delgocitinib cream vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "LEO Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 258, "start_date": "2018-11-28", "completion_date": "2020-04-20", "has_results": true, "last_update_posted_date": "2025-03-12", "last_synced_at": "2026-09-21T11:07:49.795Z", "location_count": 4, "location_summary": "Tucson, Arizona • Hialeah, Florida • Portland, Oregon", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Hialeah", "state": "Florida" }, { "city": "Portland", "state": "Oregon" }, { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT03683719" }, { "nct_id": "NCT02402309", "title": "A Study of Topical NS2 Cream to Treat Ichthyosis in Sjögren-Larsson Syndrome (SLS)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Sjögren-Larsson Syndrome" ], "interventions": [ { "name": "Active topical NS2 1% dermatologic cream", "type": "DRUG" }, { "name": "Vehicle placebo 0.0% NS2 dermatologic cream", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Aldeyra Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": null, "sex": "ALL", "summary": "6 Years and older" }, "enrollment_count": 12, "start_date": "2015-03", "completion_date": "2016-06", "has_results": true, "last_update_posted_date": "2022-12-13", "last_synced_at": "2026-09-21T11:07:49.795Z", "location_count": 3, "location_summary": "Omaha, Nebraska • Hershey, Pennsylvania • Fairfax, Virginia", "locations": [ { "city": "Omaha", "state": "Nebraska" }, { "city": "Hershey", "state": "Pennsylvania" }, { "city": "Fairfax", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02402309" }, { "nct_id": "NCT03745638", "title": "Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE AD1) - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "Ruxolitinib Cream", "type": "DRUG" }, { "name": "Vehicle Cream", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Incyte Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 631, "start_date": "2018-12-20", "completion_date": "2020-12-01", "has_results": true, "last_update_posted_date": "2023-09-28", "last_synced_at": "2026-09-21T11:07:49.795Z", "location_count": 42, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Fountain Valley, California + 35 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Oceanside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03745638" }, { "nct_id": "NCT02427724", "title": "The Effect of Topical Anesthetics on Patients' Pain and Operative Experience During Treatment With QSwitched Laser", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Lentigo" ], "interventions": [ { "name": "lidocaine 2.5%/prilocaine 2.5% topical anesthetic", "type": "DRUG" }, { "name": "lidocaine 7%/tetracaine 7% topical anesthetic", "type": "DRUG" }, { "name": "placebo vehicle", "type": "DRUG" }, { "name": "Q-switched 532nm Laser", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "25 Years", "maximum_age": "65 Years", "sex": "FEMALE", "summary": "25 Years to 65 Years · Female only" }, "enrollment_count": 48, "start_date": "2015-04", "completion_date": "2024-05-30", "has_results": false, "last_update_posted_date": "2026-07-01", "last_synced_at": "2026-09-21T11:07:49.795Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02427724" } ] }